Skip to content

Heart attack link to abacavir persists in D:A:D study

After 2008, fewer people at high risk of a heart attack were prescribed abacavir, but the appararent link to the drug remains. Image credit: Caroline Sabin / D:A:D study.

Daclatasvir plus simeprevir are effective against hepatitis C genotype 1b

Christophe Hézode, from Hôpital Henri Mondor in Paris, presenting at CROI 2014. Photo by Liz Highleyman, hivandhepatitis.com.

Efavirenz-based ART matches lopinavir/ritonavir for perinatal HIV treatment

Massive scale-up of HIV testing, plus HIV treatment on diagnosis, needed to curtail UK gay epidemic

Only having sex with same-status partners is an HIV prevention strategy for 40% of gay men

Sexually transmitted infections greatly increase the risk of HIV infection in pregnancy

New NNRTI doravirine matches efavirenz for first-line HIV treatment

Javier Morales-Ramirez presenting at CROI 2014. Photo by Liz Highleyman, hivandhepatitis.com.

Lopinavir/ritonavir or 3TC PrEP equally protective against infant HIV infection during breastfeeding

Heart attack risk in people with HIV may be falling – but not in women

Heart attack risk in people with HIV may be falling – but not in women